Evidence map›Paper›PMID 36104630›Full record

ArticleAnnals of hematology2022

Adverse outcome associated with daratumumab-based treatments in relapsed/refractory multiple myeloma patients with amplification of chromosome arm 1q21: a single-center retrospective experience.

Emiliano Barbieri, Monica Maccaferri, Giovanna Leonardi, Francesca Giacobbi, Giorgia Corradini, Ivana Lagreca, Patrizia Barozzi, Leonardo Potenza, Roberto Marasca, Mario Luppi

Open access · hybridAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of hematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. The numerous facets of 1q21Oncology letters · 2024
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Emiliano BarbieriHematology Unit and Chair, Azienda Ospedaliera Universitaria Di Modena and Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy. emilianobarbieri33@gmail.com.ORCID 0000-0003-3148-6608
Monica MaccaferriHematology Unit and Chair, Azienda Ospedaliera Universitaria Di Modena and Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Giovanna LeonardiHematology Unit and Chair, Azienda Ospedaliera Universitaria Di Modena and Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Francesca GiacobbiHematology Unit and Chair, Azienda Ospedaliera Universitaria Di Modena and Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Giorgia CorradiniHematology Unit and Chair, Azienda Ospedaliera Universitaria Di Modena and Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Ivana LagrecaHematology Unit and Chair, Azienda Ospedaliera Universitaria Di Modena and Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Patrizia BarozziHematology Unit and Chair, Azienda Ospedaliera Universitaria Di Modena and Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Leonardo PotenzaHematology Unit and Chair, Azienda Ospedaliera Universitaria Di Modena and Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Roberto Marasca *Hematology Unit and Chair, Azienda Ospedaliera Universitaria Di Modena and Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Mario Luppi *Hematology Unit and Chair, Azienda Ospedaliera Universitaria Di Modena and Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.
University of Modena and Reggio Emilia · IT

Funding

Associazione Italiana Contro le Leucemie - Linfomi e Mieloma Charity Dinner Initiative" in memory of Alberto FontanaAssociazione Italiana per la Ricerca sul Cancro IG 20624-2018Ministero dell'Istruzione, dell'Università e della Ricerca Progetto di Eccellenza Dipartimento MIUR 2017
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Multiple MyelomaNeoplasms, Plasma CellAntibodies, MonoclonalAntineoplastic Combined Chemotherapy ProtocolsChromosomesHumansRetrospective StudiesAntibodies, MonoclonaldaratumumabChromosome 1q amplificationChromosome 1q gain/amplificationDaratumumabMultiple myelomaRelapsed-refractory multiple myelomaTo the editor

Identifiers

PMID36104630
PMCPMC9646578
OpenAlexW4295792623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.